T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2019 Update
August 2019
40
About the Report
About the Report
Summary
T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company's T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company's products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company T2 Biosystems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
T2 Biosystems Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
OpGen Inc
GenMark Diagnostics Inc
Diadexus Inc
Celula Inc
BioFire Diagnostics Inc
Becton Dickinson and Co
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
T2 Biosystems Inc Company Overview
T2 Biosystems Inc Company Snapshot
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
T2 Biosystems Inc-Pipeline Analysis Overview
T2 Biosystems Inc-Key Facts
T2 Biosystems Inc-Major Products and Services
T2 Biosystems Inc Pipeline Products by Development Stage
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
T2 Biosystems Inc Pipeline Products Overview
T2Carba Resistance+
T2Carba Resistance+ Product Overview
T2Dx-Cancer
T2Dx-Cancer Product Overview
T2Dx-Cardiac
T2Dx-Cardiac Product Overview
T2Endotoxin
T2Endotoxin Product Overview
T2HemoStat
T2HemoStat Product Overview
T2Lyme Panel
T2Lyme Panel Product Overview
T2Lyme Panel Clinical Trial
T2MR Assay-Platelet Function Testing
T2MR Assay-Platelet Function Testing Product Overview
T2Plex
T2Plex Product Overview
T2Resistance Panel
T2Resistance Panel Product Overview
T2Resistance Panel-Expansion
T2Resistance Panel-Expansion Product Overview
T2 Biosystems Inc-Key Competitors
T2 Biosystems Inc-Key Employees
T2 Biosystems Inc-Key Employee Biographies
T2 Biosystems Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
T2 Biosystems Inc, Recent Developments
Aug 16, 2019: T2 Biosystems expands access to its innovative rapid diagnostic technologies to Australia, Fiji and New Zealand
Aug 06, 2019: T2Bacteria Panel is the first and only in-vitro diagnostic test to receive approval for a new technology add-on payment by CMS
Jul 30, 2019: T2 Biosystems reports second quarter 2019 financial results and provides corporate update
Jul 29, 2019: T2 Biosystems to offer diagnostic panels in new markets
Jun 28, 2019: T2 Biosystems named one of the fastest-growing companies in Massachusetts
Jun 20, 2019: T2 Biosystems introduces new clinical data and updates regarding expanding capabilities of its rapid diagnostic technology at ASM Microbe 2019
Jun 17, 2019: T2 Biosystems highlights current and future opportunities for its breakthrough rapid diagnostic technology for biothreat pathogen detection
Jun 12, 2019: T2 Biosystems to highlight its products and technology at Upcoming Medical Meetings
Jun 06, 2019: New studies highlight potential for T2Bacteria and T2Candida panels to improve outcomes and be cost-effective for sepsis patients in the Medical Intensive Care Unit and Emergency Department
May 24, 2019: T2 Biosystems to participate in Singular Research Spring Select Web Call
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
T2 Biosystems Inc Pipeline Products by Equipment Type
T2 Biosystems Inc Pipeline Products by Development Stage
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
T2 Biosystems Inc Pipeline Products by Equipment Type
T2 Biosystems Inc Pipeline Products by Indication
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
T2 Biosystems Inc, Key Facts
T2 Biosystems Inc, Major Products and Services
T2 Biosystems Inc Number of Pipeline Products by Development Stage
T2 Biosystems Inc Pipeline Products Summary by Development Stage
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
T2 Biosystems Inc Ongoing Clinical Trials Summary
T2Carba Resistance+-Product Status
T2Carba Resistance+-Product Description
T2Dx-Cancer-Product Status
T2Dx-Cancer-Product Description
T2Dx-Cardiac-Product Status
T2Dx-Cardiac-Product Description
T2Endotoxin-Product Status
T2Endotoxin-Product Description
T2HemoStat-Product Status
T2HemoStat-Product Description
T2Lyme Panel-Product Status
T2Lyme Panel-Product Description
T2Lyme Panel-Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
T2MR Assay-Platelet Function Testing-Product Status
T2MR Assay-Platelet Function Testing-Product Description
T2Plex-Product Status
T2Plex-Product Description
T2Resistance Panel-Product Status
T2Resistance Panel-Product Description
T2Resistance Panel-Expansion-Product Status
T2Resistance Panel-Expansion-Product Description
T2 Biosystems Inc, Key Employees
T2 Biosystems Inc, Key Employee Biographies
T2 Biosystems Inc, Other Locations
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.